United States radiation oncologists' and urologists' opinions about screening and treatment of prostate cancer vary by region

Author： McNaughton Collins M.   Barry M.J.   Zietman A.   Albertsen P.C.   Talcott J.A.   Walker Corkery E.   Elliott D.B.   Fowler F.J.  

Publisher： Elsevier

ISSN： 0090-4295

Source： Urology, Vol.60, Iss.4, 2002-10, pp. : 628-633

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

High-risk prostate cancer in the United States, 1990–2007

By Cooperberg Matthew   Cowan Janet   Broering Jeannette   Carroll Peter  

World Journal of Urology, Vol. 26, Iss. 3, 2008-06 ,pp. : 211-218

Springer Publishing Company

Access to resources Recommend Favorite

The Role of Urologists in the Management of Hormone-Refractory Prostate Cancer

By Pummer K.  

European Urology Supplements, Vol. 1, Iss. 2, 2002-05 ,pp. : 24-28

Elsevier

Access to resources Recommend Favorite

Epidemiology of prostate cancer in the Umbria region of Italy: evidence of opportunistic screening effects

By La Rosa F.   Stracci F.   Minelli L.   Mastrandrea V.  

Urology, Vol. 62, Iss. 6, 2003-12 ,pp. : 1040-1044

Elsevier

Access to resources Recommend Favorite

Impact of prostate-specific antigen screening on prostate cancer

By Zincke H.  

Urology, Vol. 47, Iss. 5, 1996-05 ,pp. : 783-783

Elsevier

Access to resources Recommend Favorite

Explaining the difference in prostate cancer mortality rates between white and black men in the United States

By Merrill R.M.   Lyon J.L.  

Urology, Vol. 55, Iss. 5, 2000-05 ,pp. : 730-735

Elsevier

Access to resources Recommend Favorite